Concerta and Tendon disorder - a phase IV clinical study of FDA data
Summary:
Tendon disorder is reported as a side effect among people who take Concerta (methylphenidate hydrochloride), especially for people who are female, 60+ old, also take Ambien, and have Metastases to bone.
The phase IV clinical study analyzes which people have Tendon disorder when taking Concerta. It is created by eHealthMe based on reports of 20,995 people who have side effects when taking Concerta from the FDA, and is updated regularly.
What is Concerta?
Concerta has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 25,040 Concerta users. Check the latest studies of Concerta.
What is Tendon disorder?
Tendon disorder (disease of tendon) is found to be associated with 681 drugs and 726 conditions by eHealthMe. Check the latest studies of Tendon disorder.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
20,995 people reported to have side effects when taking Concerta.
Among them, 20 people (0.1%) have Tendon disorder.

Among these 20 people:
What is the gender of people who have Tendon disorder when taking Concerta? *
- female: 90 %
- male: 10 %
What is the age of people who have Tendon disorder when taking Concerta? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 5.26 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 5.26 %
- 60+: 89.47 %
What are other drugs people take besides Concerta? *
- Zometa: 18 people, 90.00%
- Aredia: 18 people, 90.00%
- Flexeril: 18 people, 90.00%
- Peridex: 18 people, 90.00%
- Ambien: 18 people, 90.00%
- Meloxicam: 17 people, 85.00%
- Maxipime: 17 people, 85.00%
- Neurontin: 17 people, 85.00%
- Lortab: 17 people, 85.00%
- Pepcid: 17 people, 85.00%
What are other side effects people have besides Tendon disorder? *
- Weight Decreased: 18 people, 90.00%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 18 people, 90.00%
- Osteonecrosis Of Jaw (death of bone of jaw): 18 people, 90.00%
- Anaemia (lack of blood): 18 people, 90.00%
- Dyspnea (difficult or laboured breathing): 18 people, 90.00%
- Haematochezia (passage of stools containing blood): 17 people, 85.00%
- Loose Tooth: 17 people, 85.00%
- Localised Infection (infection at the single location): 17 people, 85.00%
- Joint Pain: 17 people, 85.00%
- Joint Effusion (presence of extra fluid in joint covering): 17 people, 85.00%
What are the existing conditions these people have? *
- Metastases To Bone (cancer spreads to bone): 17 people, 85.00%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.00%
- Multiple Myeloma (cancer of the plasma cells): 1 person, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Concerta and have Tendon disorder?
- Check whether Tendon disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Concerta:
- Concerta (25,040 reports)
Tendon disorder treatments and more:
- Tendon disorder (8,147 reports)
How severe was Tendon disorder and when was it recovered:
Expand to all the drugs that have ingredients of methylphenidate hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Concerta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Tendon disorder:
- Tendon disorder (681 drugs)
Browse all the conditions that are associated with Tendon disorder:
- Tendon disorder (726 conditions)
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Concerta) and Concerta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Coumadin and Upset Stomach for Women aged 20-29 - now
- Could Amoxicillin cause Pancreatitis Necrotising? - now
- Coumadin and Stomach Upset for Women aged 20-29 - a second ago
- Coumadin and Emesis for Women aged 20-29 - a second ago
- Coumadin and Nausea And Vomiting for Women aged 20-29 - 2 seconds ago
- Desogestrel; Ethinyl vs. Depo-Estradiol, side effect and effectiveness comparison - 3 seconds ago
- Could Losartan Potassium And Hydrochlorothiazide cause Hypotension? - 3 seconds ago
- Drug interactions of Saw Palmetto and Morphine - 6 seconds ago
- Drug interactions of Tagamet and Clonidine - 7 seconds ago
- Could Celebrex cause Limb Deformity? - 11 seconds ago